Decision analysis and treatment threshold in a management for the N0 neck of the oral cavity carcinoma

Oral Oncology

Volumn 45, Issue 10, 2009, Pages 908-911

  Okura, Masaya ^a   Aikawa, Tomonao ^a   Sawai, Natsuko Yoshimura ^a   Iida, Seiji ^a   Kogo, Mikihiko ^a  

^a OSAKA UNIVERSITY DENTAL HOSPITAL   (Japan)

Author keywords

Decision tree; Elective neck dissection; Head and neck cancer; N0 neck; Occult metastasis; Oral cavity cancer; Wait and see

Indexed keywords

ADULT; AGED; ARTICLE; CALCULATION; CANCER RECURRENCE; CLINICAL DECISION MAKING; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOUTH CARCINOMA; NECK DISSECTION; NECK METASTASIS; OCCULT CANCER; ORAL CAVITY SQUAMOUS CELL CARCINOMA; OVERALL SURVIVAL; PRIORITY JOURNAL; PROBABILITY; SENSITIVITY ANALYSIS; SQUAMOUS CELL CARCINOMA; SURVIVAL TIME;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; DECISION SUPPORT TECHNIQUES; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; NECK DISSECTION; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 70349091035     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2009.03.013     Document Type: Article

References (28)

1. Shah J.P., and Patel S.G. Head and neck surgery and oncology. 3rd ed. (2003) p. 173-233
2. Okura M. Lymph node metastasis. In: Pandalai SG, editor. Recent research developments in cancer, vol. 4, Part 1. Trivandrum, India; Transworld Res Network; 2002, p. 331-337.
3. Shah J.P., Medina J.E., Shaha A.R., Schantz S.P., and Marti J.R. Cervical lymph node metastasis. Curr Probl Surg 30 3 (1993) 1-335
4. Taniguchi Y., and Okura M. Prognostic significance of perioperative blood transfusion in oral cavity squamous cell carcinoma. Head Neck 25 11 (2003) 931-936
5. Ferlito A., Rinaldo A., Silver C.E., Gourin C.G., Shah J.P., Clayman G.L., et al. Elective and therapeutic selective neck dissection. Oral Oncol 42 1 (2006) 14-25
6. Weiss M.H., Harrison L.B., and Isaacs R.S. Use of decision analysis in planning a management strategy for the stage N0 neck. Arch Otolaryngol Head Neck Surg 120 7 (1994) 699-702
7. Dias F.L., Kligerman J., Matos de Sa G., Arcuri R.A., Freitas E.Q., Farias T., et al. Elective neck dissection versus observation in stage I squamous cell carcinomas of the tongue and floor of the mouth. Otolaryngol Head Neck Surg 125 1 (2001) 23-29
8. Greenberg J.S., El Naggar A.K., Mo V., Roberts D., and Myers J.N. Disparity in pathologic and clinical lymph node staging in oral tongue carcinoma. Implication for therapeutic decision making. Cancer 98 3 (2003) 508-515
9. Haddadin K.J., Soutar D.S., Oliver R.J., Webster M.H., Robertson A.G., and MacDonald D.G. Improved survival for patients with clinically T1/T2, N0 tongue tumors undergoing a prophylactic neck dissection. Head Neck 21 6 (1999) 517-525
10. O'Brien C.J., Traynor S.J., McNeil E., McMahon J.D., and Chaplin J.M. The use of clinical criteria alone in the management of the clinically negative neck among patients with squamous cell carcinoma of the oral cavity and oropharynx. Arch Otolaryngol Head Neck Surg 126 3 (2000) 360-365
11. Sano D., and Myers J.N. Metastasis of squamous cell carcinoma of the oral tongue. Cancer Metast Rev 26 3-4 (2007) 645-662
12. Wei W.I., Ferlito A., Rinaldo A., Gourin C.G., Lowry J., Ho W.K., et al. Management of the N0 neck - reference or preference. Oral Oncol 42 2 (2006) 115-122
13. Andersen P.E., Cambronero E., Shaha A.R., and Shah J.P. The extent of neck disease after regional failure during observation of the N0 neck. Am J Surg 172 6 (1996) 689-691
14. Bourgier C., Coche-Dequeant B., Fournier C., Castelain B., Prevost B., Lefebvre J.L., et al. Exclusive low-dose-rate brachytherapy in 279 patients with T2N0 mobile tongue carcinoma. Int J Radiat Oncol Biol Phys 63 2 (2005) 434-440
15. Brazilian H., Neck, Cancer, Study, and Group. Results of a prospective trial on elective modified radical classical versus supraomohyoid neck dissection in the management of oral squamous carcinoma. Brazilian Head and Neck Cancer Study Group. Am J Surg 176 5 (1998) 422-427
16. Byers R.M., El-Naggar A.K., Lee Y.Y., Rao B., Fornage B., Terry N.H., et al. Can we detect or predict the presence of occult nodal metastases in patients with squamous carcinoma of the oral tongue?. Head Neck 20 2 (1998) 138-144
17. Franceschi D., Gupta R., Spiro R.H., and Shah J.P. Improved survival in the treatment of squamous carcinoma of the oral tongue. Am J Surg 166 4 (1993) 360-365
18. Huang S.F., Kang C.J., Lin C.Y., Fan K.H., Yen T.C., Wang H.M., et al. Neck treatment of patients with early-stage oral tongue cancer: comparison between observation, supraomohyoid dissection, and extended dissection. Cancer 112 5 (2008) 1066-1075
19. Kaya S., Yilmaz T., Gursel B., Sarac S., and Sennaroglu L. The value of elective neck dissection in treatment of cancer of the tongue. Am J Otolaryngol 22 1 (2001) 59-64
20. Yuen A.P., Wei W.I., Wong Y.M., and Tang K.C. Elective neck dissection versus observation in the treatment of early oral tongue carcinoma. Head Neck 19 7 (1997) 583-588
21. NCCN practice guidelines for cancer of the head and neck v.2.2008. Available from: .
22. Okura M., Hiranuma T., Adachi T., Ogura T., Aikawa T., Yoshioka H., et al. Induction chemotherapy is associated with an increase in the incidence of loco regional recurrence in patients with carcinoma of the oral cavity: results from a single institution. Cancer 82 5 (1998) 804-815
23. Kitahara S., Ikeda M., Inouye T., Matsunaga T., Yamaguchi K., Takayama E., et al. Inhibition of head and neck metastatic and/or recurrent cancer by local administration of multi-cytokine inducer OK-432. J Laryngol Otol 110 5 (1996) 449-453
24. van den Brekel M.W., Castelijns J.A., Reitsma L.C., Leemans C.R., van der Waal I., and Snow G.B. Outcome of observing the N0 neck using ultrasonographic-guided cytology for follow-up. Arch Otolaryngol Head Neck Surg 125 2 (1999) 153-156
25. Goto M., Hasegawa Y., Terada A., Hyodo I., Hanai N., Ijichi K., et al. Prognostic significance of late cervical metastasis and distant failure in patients with stages I and II oral tongue cancers. Oral Oncol 41 1 (2005) 62-69
26. Kaneko S., Yoshimura T., Ikemura K., Shirasuna K., Kusukawa J., Ohishi M., et al. Primary neck management among patients with cancer of the oral cavity without clinical nodal metastases: a decision and sensitivity analysis. Head Neck 24 6 (2002) 582-590
27. Nieuwenhuis E.J., Castelijns J.A., Pijpers R., van den Brekel M.W., Brakenhoff R.H., van der Waal I., et al. Wait-and-see policy for the N0 neck in early-stage oral and oropharyngeal squamous cell carcinoma using ultrasonography-guided cytology: is there a role for identification of the sentinel node?. Head Neck 24 3 (2002) 282-289
28. Okura M., Iida S., Aikawa T., Adachi T., Yoshimura N., Yamada T., et al. Tumor thickness and paralingual distance of coronal MR imaging predicts cervical node metastases in oral tongue carcinoma. AJNR Am J Neuroradiol 29 1 (2008) 45-50